Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57
March 9, 2026
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57